San Diego-based Organovo Holdings Inc. (OTCQX: ONVO) and ZenBio Inc. are partnering to produce three-dimensional human tissues for drug discovery and advanced tissue therapies.
Organovo Holdings is a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications.
ZenBio Inc. provides advanced cell-based solutions and services.
ZenBio will provide validated cellular inputs for use by Organovo with its NovoGen bioprinting technology to enable the generation of living, three-dimensional tissues that reproduce the architectural and functional features of tissues inside the human body.
The resulting 3-D tissue models may lead to advances in medical research, drug discovery and development, as well as direct therapies and transplantation, according to Organovo.